Full Text (PDF)
Original Article

Comparative Evaluation of Butorphanol Versus Nalbuphine for Postoperative Epidural Analgesia in Lower Limb Orthopaedic Surgeries

Haramritpal Kaur , Mukesh Kumar1 , Amit Kumar Lal2 , Haramritpal Kaur3 , Gurpreet Singh4 , Naresh Baghla5 , Harmanpreet Kaur Jhand6

Author Information

Licence:




Indian Journal of Anesthesia and Analgesia 6(2):p 611-618, MARCH-APRIL 2019. | DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6219.37

How Cite This Article:

Mukesh Kumar, Amit Kumar Lal, Haramritpal Kaur. Comparative Evaluation of Butorphanol Versus Nalbuphine for Postoperative Epidural Analgesia in Lower Limb Orthopaedic Surgeries. Indian J Anesth Analg. 2019;6(2):611-618.


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background: Epidural opioids acting through the spinal cord receptors improve the quality and duration of analgesia along with dose-sparing effect with the local anesthetics. The present study compared the efficacy and safety profile of epiduraly administered butorphanol and nalbuphine combined with ropivacaine. Materials and Methods: A total of 60 adult patients of either sex of American Society of Anesthesiologist physical status I and II, aged 18-60 years, undergoing lower limb orthopaedic surgeries under combined spinal epidural anaesthesia were enrolled into the study. Patients were randomly divided into three groups of 20 each: 0.2% Ropivacaine (group 1), 0.2% ropivacaine + 2 mg butorphanol (group 2), 0.2% ropivacaine + 10 mg Nalbuphine (group 3). The hemodynamic parameters as well as onset of pain relief and duration of analgesia were noted. Adverse events and sedation scores were also noted. Results: We found that haemodynamics were comparable in all the three groups. Onset of analgesia was earliest in Nalbuphine group (group 3) 1.45±0.51 min) followed by butorphanol group - group 2 (4.45±0.61 min) and maximum in ropivacaine plain group 1(8.30±0.97 min. The duration of analgesia was significantly prolonged in group 3 (6.40±0.821 hr) followed by butorphanol group - group 2 (4.45±0.605 hr) and shortest in plain group - group 1 (2.30±0.470 hr). Sedation was observed markedly in butorphanol group. No serious cardio respiratory side effects were observed in any group. Conclusions: Butorphanol and Nalbuphine as epidural adjuvants are equally safe and provide comparable stable hemodynamics, early onset and establishment of sensory anesthesia. Nalbuphine provides a significantly prolonged post-operative analgesia.


References

No records found.


About this article


Cite this article

Mukesh Kumar, Amit Kumar Lal, Haramritpal Kaur. Comparative Evaluation of Butorphanol Versus Nalbuphine for Postoperative Epidural Analgesia in Lower Limb Orthopaedic Surgeries. Indian J Anesth Analg. 2019;6(2):611-618.


Licence:




Received Accepted Published
N/A N/A N/A

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.6219.37

Keywords

Ropivacaine; butorphanol; epidural anesthesia; nalbuphine; lower limb orthopaedic surgery.

Article Level Metrics

Last Updated

Saturday 07 February 2026, 21:03:20 (IST)


1189

Accesses

0
194
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share